Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Virology. 2016 Jan 14;489:282–291. doi: 10.1016/j.virol.2015.12.015

Fig. 10.

Fig. 10

CypB enhancement does not require Stat5 activity. (A) Infection assays. 293T cells were transfected with either pcDNA3.1 empty vector or CypB. The following day media was changed and the cells pre-treated with indicated concentrations of STAT5 inhibitor for 4 h prior to transduction with NLX-Luc. At 48hpi cells were lysed and assayed for Luc activity, which was normalized to protein total protein concentration. Results are presented relative to infected control cells treated with DMSO and statistical differences analyzed by two-tailed t-test (** = p<0.0001 and * = p<0.05). (B) MTT assay of cells treated with Stat5 inhibitor. (C) Cell cycle analysis of cells treated with 5, 50, or 200 μM Stat5 inhibitor.